Tenzing Acquisition Corp
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $50M
- Underwriters
- SEC Filings
- 1742927
- Public Embarc Page
- https://embarc.com/capital/spac/1742927/TZAC/tenzing-acquisition
- IPO Ticker
- TZAC
SPAC Leadership
Information on the SPAC leadership.
- Chairman of the BoardParag Saxena
- Chief Executive Officer and DirectorRahul Nayar
- Chief Financial OfficerGonzalo Cordova
- Vice PresidentAtanuu Agarrwal
- Independent DirectorWilliam I. Campbell
- DirectorNina Shapiro
- DirectorVikas Thapar
- DirectorWilliam Campbell
Target Information
Information on the SPAC target for merger.
- Company
- Reviva Pharma
- Presentation
- Investor Presentation (SEC) on 2020-11-06
- Description
- Reviva is a California-based clinical stage pharmaceutical company developing therapies that address unmet medical needs in areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases.